Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke

Andrea Santamato, Nicoletta Cinone, Francesco Panza, Sara Letizia, Luigi Santoro, Madia Lozupone, Antonio Daniele, Alessandro Picelli, Alessio Baricich, Domenico Intiso, Maurizio Ranieri

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Post-stroke lower limb spasticity impairs balance and gait leading to reduced walking speed, often increasing wheelchair use and caregiver burden. Several studies have shown that appropriate treatments for lower limb spasticity after stroke include injections of botulinum toxin type A (BoNT-A), phenol or alcohol, surgical correction and a rehabilitation program. In the present article, we review the safety and effectiveness of BoNT-A for the treatment of lower limb spasticity after stroke, with a focus on higher doses of BoNT-A. The cumulative body of evidence coming from the randomized clinical trials and open-label studies selected in the article suggest BoNT-A to be safe and efficacious in reducing lower limb spasticity after stroke. Studies of high doses of BoNT-A also showed a greater reduction of severe post-stroke spasticity. In stroke survivors with spasticity of the ankle plantar-flexor muscles, a combined approach between surgery and BoNT-A can be indicated. However, controversy remains about improvement in motor function relative to post-stroke spasticity reduction after BoNT-A treatment.

Original languageEnglish
JournalDrugs
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Type A Botulinum Toxins
Lower Extremity
Stroke
Therapeutics
Wheelchairs
Phenol
Gait
Ankle
Caregivers
Survivors
Rehabilitation
Randomized Controlled Trials
Alcohols
Safety
Muscles
Injections

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Santamato, A., Cinone, N., Panza, F., Letizia, S., Santoro, L., Lozupone, M., ... Ranieri, M. (Accepted/In press). Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke. Drugs. https://doi.org/10.1007/s40265-018-1042-z

Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke. / Santamato, Andrea; Cinone, Nicoletta; Panza, Francesco; Letizia, Sara; Santoro, Luigi; Lozupone, Madia; Daniele, Antonio; Picelli, Alessandro; Baricich, Alessio; Intiso, Domenico; Ranieri, Maurizio.

In: Drugs, 01.01.2019.

Research output: Contribution to journalArticle

Santamato, A, Cinone, N, Panza, F, Letizia, S, Santoro, L, Lozupone, M, Daniele, A, Picelli, A, Baricich, A, Intiso, D & Ranieri, M 2019, 'Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke', Drugs. https://doi.org/10.1007/s40265-018-1042-z
Santamato A, Cinone N, Panza F, Letizia S, Santoro L, Lozupone M et al. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke. Drugs. 2019 Jan 1. https://doi.org/10.1007/s40265-018-1042-z
Santamato, Andrea ; Cinone, Nicoletta ; Panza, Francesco ; Letizia, Sara ; Santoro, Luigi ; Lozupone, Madia ; Daniele, Antonio ; Picelli, Alessandro ; Baricich, Alessio ; Intiso, Domenico ; Ranieri, Maurizio. / Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke. In: Drugs. 2019.
@article{9a7eed354265447196612a58dd2ea08f,
title = "Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke",
abstract = "Post-stroke lower limb spasticity impairs balance and gait leading to reduced walking speed, often increasing wheelchair use and caregiver burden. Several studies have shown that appropriate treatments for lower limb spasticity after stroke include injections of botulinum toxin type A (BoNT-A), phenol or alcohol, surgical correction and a rehabilitation program. In the present article, we review the safety and effectiveness of BoNT-A for the treatment of lower limb spasticity after stroke, with a focus on higher doses of BoNT-A. The cumulative body of evidence coming from the randomized clinical trials and open-label studies selected in the article suggest BoNT-A to be safe and efficacious in reducing lower limb spasticity after stroke. Studies of high doses of BoNT-A also showed a greater reduction of severe post-stroke spasticity. In stroke survivors with spasticity of the ankle plantar-flexor muscles, a combined approach between surgery and BoNT-A can be indicated. However, controversy remains about improvement in motor function relative to post-stroke spasticity reduction after BoNT-A treatment.",
author = "Andrea Santamato and Nicoletta Cinone and Francesco Panza and Sara Letizia and Luigi Santoro and Madia Lozupone and Antonio Daniele and Alessandro Picelli and Alessio Baricich and Domenico Intiso and Maurizio Ranieri",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s40265-018-1042-z",
language = "English",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke

AU - Santamato, Andrea

AU - Cinone, Nicoletta

AU - Panza, Francesco

AU - Letizia, Sara

AU - Santoro, Luigi

AU - Lozupone, Madia

AU - Daniele, Antonio

AU - Picelli, Alessandro

AU - Baricich, Alessio

AU - Intiso, Domenico

AU - Ranieri, Maurizio

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Post-stroke lower limb spasticity impairs balance and gait leading to reduced walking speed, often increasing wheelchair use and caregiver burden. Several studies have shown that appropriate treatments for lower limb spasticity after stroke include injections of botulinum toxin type A (BoNT-A), phenol or alcohol, surgical correction and a rehabilitation program. In the present article, we review the safety and effectiveness of BoNT-A for the treatment of lower limb spasticity after stroke, with a focus on higher doses of BoNT-A. The cumulative body of evidence coming from the randomized clinical trials and open-label studies selected in the article suggest BoNT-A to be safe and efficacious in reducing lower limb spasticity after stroke. Studies of high doses of BoNT-A also showed a greater reduction of severe post-stroke spasticity. In stroke survivors with spasticity of the ankle plantar-flexor muscles, a combined approach between surgery and BoNT-A can be indicated. However, controversy remains about improvement in motor function relative to post-stroke spasticity reduction after BoNT-A treatment.

AB - Post-stroke lower limb spasticity impairs balance and gait leading to reduced walking speed, often increasing wheelchair use and caregiver burden. Several studies have shown that appropriate treatments for lower limb spasticity after stroke include injections of botulinum toxin type A (BoNT-A), phenol or alcohol, surgical correction and a rehabilitation program. In the present article, we review the safety and effectiveness of BoNT-A for the treatment of lower limb spasticity after stroke, with a focus on higher doses of BoNT-A. The cumulative body of evidence coming from the randomized clinical trials and open-label studies selected in the article suggest BoNT-A to be safe and efficacious in reducing lower limb spasticity after stroke. Studies of high doses of BoNT-A also showed a greater reduction of severe post-stroke spasticity. In stroke survivors with spasticity of the ankle plantar-flexor muscles, a combined approach between surgery and BoNT-A can be indicated. However, controversy remains about improvement in motor function relative to post-stroke spasticity reduction after BoNT-A treatment.

UR - http://www.scopus.com/inward/record.url?scp=85059862000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059862000&partnerID=8YFLogxK

U2 - 10.1007/s40265-018-1042-z

DO - 10.1007/s40265-018-1042-z

M3 - Article

AN - SCOPUS:85059862000

JO - Drugs

JF - Drugs

SN - 0012-6667

ER -